Plaque is a major cause of gum disease1 and according to the Group B consensus report of the fifth European Workshop in Periodontology, '...oral plaque biofilm disruption is the most effective way to treat and prevent both conditions [gingivitis and periodontitis]'.2
In line with this, LISTERINE® Advanced Defence Gum Treatment is clinically proven to interrupt the plaque colonisation process.3
LISTERINE® Advanced Defence Gum Treatment is formulated with unique LAE (ethyl lauroyl arginate) technology that forms a physical coating on the pellicle to prevent bacteria attaching, and so interrupts biofilm formation. When used after brushing it treats gum disease, as indicated by the reduction of bleeding by 50.9% (p <0.001) in only four weeks.3
Advanced Defence Gum Treatment is part of the LISTERINE® Advanced Defence range from Johnson & Johnson, a scientifically proven adjunct to your professional treatment.
For more information on LISTERINE® Advanced Defence, visit www.listerineprofessional.co.uk or call 0800 328 0750.
References
Page R C, Kornman K S . The pathogenesis of human periodontitis: an introduction. Periodontol 2000 1997; 14: 9–11.
Kinane D F, Attstrom R . Advances in the pathogenesis of periodontitis. Group B consensus report of the fifth European Workshop in Periodontology. J Clin Periodontol 2005; 32(Suppl 6): 130–131.
Bleeding Index Reduction DOF 1 – 2013 (LAEBBA0001), 50.9% Reduction in whole-mouth mean Bleeding Index at 4 weeks
Rights and permissions
About this article
Cite this article
An innovative solution to help with plaque management. Br Dent J 218, 364 (2015). https://doi.org/10.1038/sj.bdj.2015.234
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bdj.2015.234
